Xiaomei Mo
- Co-authors
- Dehai LiTianjiao ZhuAttila MándiTibor KurtánQianqun GuJing LiHuahui LiPing Zhu
- Topics
- Microbial Natural Products and Biosynthesis (5 papers)MicroRNA in disease regulation (3 papers)Bioactive Compounds and Antitumor Agents (2 papers)
- Cited by
- BiotechnologyPharmacologyToxicology
- Journals
- SHILAP Revista de lepidopterologíaOrganic LettersEuropean Journal of Medicinal Chemistry
In The Last Decade
Xiaomei Mo
18 papers receiving 413 citations
Peers
Comparison fields: 5 of 65
- Molecular Biology 178
- Pharmacology 174
- Biotechnology 97
- Organic Chemistry 88
- Cancer Research 76
Countries citing papers authored by Xiaomei Mo
This map shows the geographic impact of Xiaomei Mo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaomei Mo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaomei Mo more than expected).
Fields of papers citing papers by Xiaomei Mo
This network shows the impact of papers produced by Xiaomei Mo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaomei Mo. The network helps show where Xiaomei Mo may publish in the future.
Co-authorship network of co-authors of Xiaomei Mo
This figure shows the co-authorship network connecting the top 25 collaborators of Xiaomei Mo. A scholar is included among the top collaborators of Xiaomei Mo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaomei Mo. Xiaomei Mo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 3 | |
| 3 | 4 | |
| 4 | 2 | |
| 5 | 6 | |
| 6 | 32 | |
| 7 | 26 | |
| 8 | 24 | |
| 9 | 53 | |
| 10 | 1 | |
| 11 | 74 | |
| 12 | 22 | |
| 13 | 20 | |
| 14 | 15 | |
| 15 | [Contemplation and suggestion on the medical device adverse event reporting program]. | 2 |
| 16 | 59 | |
| 17 | 61 | |
| 18 | 6 |
About Xiaomei Mo
Xiaomei Mo is a scholar working on Medical Laboratory Technology, Toxicology and Applied Microbiology and Biotechnology, having authored 18 papers that have together received 417 indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (5 papers), MicroRNA in disease regulation (3 papers) and Bioactive Compounds and Antitumor Agents (2 papers). The work is most often cited by research in Biotechnology (97 citations), Pharmacology (174 citations) and Toxicology (25 citations). Xiaomei Mo has collaborated with scholars based in China, Hungary and Hong Kong. Frequent co-authors include Dehai Li, Tianjiao Zhu, Attila Mándi, Tibor Kurtán, Qianqun Gu, Jing Li, Huahui Li, Ping Zhu, George Y. Chen and Guangwei Wu. Their work appears in journals such as SHILAP Revista de lepidopterología, Organic Letters and European Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.